3[3]Tsai SL. Immunopathogenesis of viral hepatitis B and C. Chang Keng I Hsueh Tsa Chih, 1999, 22:159
4[4]Kakimi K, Lane TE, Wieland S, et al. Blocking chemokine responsive to gamma- 2/interferon (IFN)- gamma inducible protein and monokine induced by IFN- gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus- specific cytotoxic T lymphocytes. J Exp Med, 2001, 194:1755
6[6]Kakimi K, Lane TE, Chisari FV, et al. Cutting edge: Inhibi_ tion of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver. J Immunol, 2001, 167:6701
7[7]Guidotti LG, Chisari FV. Noncytolytic control of viral infec_ tions by the innate and adaptive immune response. Annu Rev Immunol, 2001,19:65
8[8]Webster GJM,Reignat S,and Bertoletti A et al:Incubation phase of acute hepatitis B in Man:dynamic of cellular immune mechanisms.Hepatology,2000;32:1117
9[9]Cavanaugh VJ, Guidotti LG, Chisari FV. Inhibition of hep_ atitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J Virol, 1998, 72:2630
10[10]Guidotti LG, Rochford R, Chung J, et al. Viral clearance without destruction of infected cells during acute HBV infec tion. Science, 1999, 284:825
3Chen H,Paul WE.A population of CD62Llow Nk1.1-CD4+ T cells that resembles NK1.1-CD4+ T cells[J].Eur J Immunol,1998,28(10):317231.
4Omid Akbari,Philippe Stock,Everett Meyer.Essential role of NKT cells producing IL-4 and IL-13 in the development of a llergen-induced airway hyperreactivity[J].J Nature Medicine,2003,9(5),582.
5Guidotti LG,Rochford R,Chung J,et al.Viral clearance without destruction of infected cells during acute HBV infection[J].Science,1999,284(5415):825.
6Baron JL Gardiner L,Nishimura S,et al.Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection[J].immunity,2002,16(4):583.
7Minagawa M,Deng Q,Liu ZX.Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption[J].Gastroenterology,2004,126(5):1387.
8Rosen HR.Hepatitis C virus in the human liver transplantation model[J].Clin Liver Dis,2003,7(1):107.
9Yonekura K,Ichida T,Sato K,et al.Liver-infiltrating CD56 positive T lymphocytes in hepatitis C virus infection[J].Liver,2000,20(5):357.
10Kawarabayashi N,Seki S,Hatsuse K,et al.Decrease of CD56 (+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma[J].Hepatology,2000,32 (5):962.